August 11, 2025
After a pandemic-fueled boom and a 2022–2023 correction, health tech is re-emerging in 2025 but with a very different profile. The sector is no longer riding a wave of telehealth hype or COVID-response funding. Instead, investors are gravitating toward infrastructure, diagnostics, and AI-integrated platforms that drive long-term efficiencies and clinical outcomes.
đź’¸ Investment Climate: Return of Discipline
According to Rock Health, venture funding for U.S. digital health companies reached $6.1B in the first half of 2025 which is up slightly from 2024, but still far below the 2021 highs. What do we need to keep an eye here? Quality over volume. VCs have moved past chasing “Zoom-for-healthcare” clones. In 2025, they’re backing startups with strong unit economics, regulatory clarity, and evidence-based outcomes. Back to basics, here we go!
Early-stage deals (Seed and Series A) are heating up again, especially for companies tackling care delivery gaps, clinical automation, and chronic condition management. High level, check out trends on Carta’s data on how Seed/Series A companies have an easier time getting funding.
đź“Š 3 Health Tech Trends VCs Should Be Watching
1. AI in Diagnostics Is Getting Real
Generative and computer vision-based AI is moving from slide decks into hospitals. Startups like PathAI and Viz.ai are showing how AI can assist with radiology, pathology, and early disease detection. What’s changed?
- Improved FDA frameworks (e.g., Software as a Medical Device – SaMD)
- Better explainability tools
- AI-human collaboration models that prioritize safety and liability balance
VCs are watching for: differentiated data access, proprietary annotation workflows, and reimbursement pathways.
2. Infrastructure Is the New Frontier
Rather than patient-facing apps, many startups are now selling to payers, health systems, or pharma, building the “picks and shovels” of modern healthcare. This includes:
- Interoperability APIs
- Clinical workflow automation
- Real-world evidence (RWE) platforms
- Privacy-preserving data sharing (e.g. federated learning)
Why it matters: The U.S. health system remains fragmented, under-digitized, and wildly inefficient. Startups that help incumbents move faster without overhauling everything are gaining traction.
3. Behavioral & Preventive Health Is Maturing
Mental health apps are consolidating, but the demand remains. Investors are now looking for startups that combine:
- Strong engagement + clinical rigor
- Personalized, AI-supported coaching
- Seamless integration into employer or payer ecosystems
Prevention and behavior change (e.g., metabolic health, MSK, cardiovascular risk) are also attracting attention, especially when paired with sensors, computer vision (as seen in Hinge Health), or longitudinal monitoring.
🧠VC Takeaways
- Back integrated systems, not standalone apps. Platforms that plug into care delivery, EHRs, and reimbursement systems have higher staying power.
- Watch the AI-regulatory space. The FDA’s evolving clarity on AI tools opens doors for clinically responsible innovation.
- Favor infrastructure + workflows. Tools that empower existing providers or systems scale more efficiently than consumer-first models in this climate.
Health tech isn’t “back” the way it was in 2021. Today we’re moving into a more disciplined, infrastructure-focused, and clinically integrated sector. For VCs willing to go beyond surface-level innovation and dig into the regulatory, clinical, and operational layers of the market, the opportunity is still massive.